Wherever we're developing regulations, the minimum requirement to achieve the policy objective is our best objective. If there are appropriate measures in place at a provincial level or standards across, whereby we don't need to enter into that space, then we wouldn't enter into that space.
There are always going to be times when we're co-regulating in different areas. On the drug side, for example, we're interested in the security of the supply chain for the drugs, but at the pharmacy level, pharmacists are regulated by provincial colleges. We both regulate at the pharmacy level: we from a security perspective in terms of the integrity of the supply chain, and then others in terms of the practice of pharmacy.
There are times when we have to be in the same space, but we do look at where we can find reductions in duplication. This is very much a lens through which we look at our cost-benefit analysis when we're developing regulatory packages, when we're looking at burden reduction. We want to ensure that we eliminate duplication wherever we can.